A Quality By Design Approach to Clinical Trial Monitoring and eTMF Integration
Learn best practices for implementing a Quality by Design approach to remote site monitoring and eTMF compliance and inspection readiness.
Four Ways to Value Your Early Drug Candidate
In the process of finding a partner and negotiating an agreement, a central question arises: What is my drug candidate worth?
Best Practices for Selecting Medical Device Suppliers
Maren Nelson has developed multiple medical devices during her career. Her projects have included internal and external resources for both the development and manufacturing of new products and product changes. Maren currently consults on medical product development strategy and Quality Management System implementation and improvements.
How to Organize a Virtual Data Room for Biopharma Partnering
But successful biopharma partnerships don't happen by chance and negotiating an out-licensing deal can be complex—especially when the company may also be progressing the clinical portfolio.
5 Actionable M&A Insights From Sharevault’s CEO
In August of 2019, ShareVault founder and CEO Richard Andersen participated in a web panel hosted by Expert Webcast to share his entrepreneurial expertise in concert with corporate counsel, due diligence and investment banking professionals from Blank Rome, FTI Consulting and DelMorgan & Co.
Maximizing M&A Value, Minimizing Surprises
Whether you're on the buy-side or the sell-side, it is important to engage early in the diligence process and the planning phase and take a structured approach to avoid surprises.
How to Securely View Excel Spreadsheets in ShareVault
Securely Viewing Excel Spreadsheets in ShareVault When users click to view a Microsoft Excel spreadsheet in ShareVault, the file is displayed in the browser using the ShareVault secure spreadsheet...
8 Ways to Accelerate Due Diligence Using ShareVault
Careful examination of your company from an external perspective and addressing potential buyers’ concerns in advance will not only increase the likelihood of receiving the price that was agreed to in the term sheet, but will also make the deal move faster and improve the chance of a successful outcome.
The Implications of COVID-19 on M&A
The coronavirus (COVID-19) has impacted just about everything, including the global M&A market. In a short period of time, businesses of all types have been forced to either shutter their doors or significantly cut back on operations. Millions of employees have been laid off or furloughed and consumer spending has been drastically reduced. Supply chains have been disrupted and shelter-in-place orders have greatly reduced the demand for gasoline and other energy resources.
M&A Value Creators & Destroyers
As a prelude to the web panel discussion, we sat down with John Hotta to find out what he believes are the major pitfalls and best practices for M&A due diligence and integration.
